Intesa Sanpaolo SpA.’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
47,004
-552
-1% -$205K 0.62% 30
2026
Q1
$13.9M Buy
47,556
+6,270
+15% +$2.06M 0.82% 26
2025
Q4
$14.4M Buy
+41,286
New +$14M 0.83% 27

Other funds holding ELV

Intesa Sanpaolo SpA.'s ELV Position: Q2 2026 in Review

Intesa Sanpaolo SpA. reduced its Elevance Health (ELV) stake by 1.2% in Q2 2026, selling an estimated $205K and leaving 47,004 shares worth $18.2M. The position accounts for 0.62% of the portfolio, ranked #30.

Intesa Sanpaolo SpA. first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Intesa Sanpaolo SpA. held 47,004 shares of Elevance Health worth $18.2M as of Q2 2026.
  • Intesa Sanpaolo SpA. sold 552 Elevance Health shares in Q2 2026, an estimated $205K.
  • Elevance Health made up 0.62% of Intesa Sanpaolo SpA.'s portfolio in Q2 2026, its #30 holding.
  • Intesa Sanpaolo SpA. first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Intesa Sanpaolo SpA.'s 13F filing for Q2 2026, filed 31 Jul 2026.